Abstract:Background and purpose: The pathophysiological features of acute ischemic stroke (AIS) often involve dysfunction of the blood-brain barrier (BBB), characterized by the degradation of tight junction proteins (Tjs) leading to increased permeability. This dysfunction can exacerbate cerebral injury and contribute to severe complications. The permeability of the BBB fluctuates during different stages of AIS and is influenced by various factors. Developing effective therapies to restore BBB function remains a significant challenge in AIS treatment. High levels of vascular endothelial growth factor (VEGF) in the early stages of AIS have been shown to worsen BBB breakdown and stroke progression. Our study aimed to investigate the protective effects of the VEGF receptor inhibitor Axitinib on BBB dysfunction and cerebral ischemia/reperfusion-induced injury. Methods: BEnd3 cell exposed to oxygen-glucose deprivation (OGD) model was constructed to estimate pharmacological activity of Axitinib (400 ng/ml) on anti-apoptosis and pathological barrier function recovery. In vivo, rats were subjected to a 1 h transient middle cerebral artery occlusion and 23 h reperfusion (tMCAO/R) to investigate the permeability of BBB and cerebral tissue damage. Axitinib was administered through the tail vein at the beginning of reperfusion. BBB integrity was assessed by Evans blue leakage and the expression levels of Tjs claudin-5 and occludin. Results: Our research revealed that co-incubation with Axitinib enhanced the cell viability of OGD-insulted bEnd3 cells, decreased LDH leakage rate, and suppressed the expression of apoptosis-related proteins cytochrome C and Bax. Axitinib also mitigated the damage to Tjs and facilitated the restoration of transepithelial electrical resistance in OGD-insulted bEnd.3 cells. In vivo, Axitinib administration reduced intracerebral Evans blue leakage and up-regulated the expression of Tjs in the penumbra brain tissue in tMCAO/R rats. Notably, 10 mg/kg Axitinib exerted a significant anti-ischemic effect by decreasing cerebral infarct volume and brain edema volume, improving neurological function, and reducing pro-inflammatory cytokines IL-6 and TNF-alpha in the brain. Conclusions: Our study highlights Axitinib as a potent protectant of blood-brain barrier function, capable of promoting pathological blood-brain barrier recovery through VEGF inhibition and increased expression of tight junction proteins in AIS. This suggests that VEGF antagonism within the first 24 h post-stroke could be a novel therapeutic approach to enhance blood-brain barrier function and mitigate ischemia-reperfusion injury.

Role of Crosstalk Between Glial Cells and Immune Cells in Blood-Brain Barrier Damage and Protection after Acute Ischemic Stroke

Crosstalk Among Glial Cells in the Blood–Brain Barrier Injury After Ischemic Stroke

The role of crosstalk between cerebral immune cells and peripheral immune cells in the damage and protection of blood-brain barrier after intracerebral hemorrhage

Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?

The Protective Effects of Axitinib on Blood-Brain Barrier Dysfunction and Ischemia-Reperfusion Injury in Acute Ischemic Stroke

RETRACTED: Role of Glial Cell-Derived Oxidative Stress in Blood-Brain Barrier Damage after Acute Ischemic Stroke (retracted Article)

Glial Cells: Role of the Immune Response in Ischemic Stroke

The role of neuroglial cells communication in ischemic stroke

Crosstalk of Astrocytes and Other Cells During Ischemic Stroke

Immune-mediated disruption of the blood-brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets

New progress in the approaches for blood–brain barrier protection in acute ischemic stroke

The Crosstalk Between Immune Cells After Intracerebral Hemorrhage

Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke

Blood-Brain Barrier Breakdown In Acute And Chronic Cerebrovascular Disease

The Relationship of Astrocytes and Microglia with Different Stages of Ischemic Stroke.

Crosstalk Between Microglia And T Cells Contributes To Brain Damage And Recovery After Ischemic Stroke

Stroke-induced damage on the blood–brain barrier

Targeting oxidative stress and inflammatory response for blood-brain barrier protection in intracerebral hemorrhage

Ischemia Reperfusion Injury Induced Blood Brain Barrier Dysfunction and the Involved Molecular Mechanism

The role of neuro-inflammatory in the pathogenesis of brain edema and hemorrhagic transformation in ischemic stroke: mechanisms and therapeutic target

The Effects and Underlying Mechanisms of Cell Therapy on Blood-Brain Barrier Integrity after Ischemic Stroke.